TE_38951
Basic information Differential Expression Stage analysis Survival analysis Correlation analysis| TE family | LTR14C |
|---|---|
| TE superfamily | ERV2 |
| TE class | LTR |
| Gene | ENSG00000293305 |
| Class | Annoated |
| Coding | Non-coding |
| Tumor-specific score | 1.32 |
| Counts of samples | TCGA_tumor:1299; TCGA_normal:69; GTEx:1039 |
| TSS | chrY(-):8126243 |
Transcript isoforms
| Transcript_ID | Gene | Class | Coding | ORF | Position |
|---|---|---|---|---|---|
| teRNA_38951.1 | ENSG00000293305 | Annoated | Non-coding | Non-coding | chrY(-):8070097,8070117,8076990,8077174,8111850,8111964,8126058,8126244 |
1
GTEx
The proportion of samples in which the TE-initiated transcript was expressed across 46 body sites in the Genotype-Tissue Expression (GTEx) project.
TCGA
The proportion of samples in which the TE-initiated transcript was expressed across 33 cancer types from The Cancer Genome Atlas (TCGA).
GTEx
The expression of TE-initiated transcript across 46 body sites from The Genotype-Tissue Expression (GTEx) project.
